PCA2- IRINOTECAN IN FIRST LINE TREATMENT OF METASTATIC COLORECTAL CANCER- IMPROVED SURVIVAL AND COST EFFECTIVENESS COMPARED WITH INFUSIONAL 5-FLUOROURACIL
Sep 1, 1999, 00:00
10.1016/S1098-3015(10)75836-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)75836-8/fulltext
Title :
PCA2- IRINOTECAN IN FIRST LINE TREATMENT OF METASTATIC COLORECTAL CANCER- IMPROVED SURVIVAL AND COST EFFECTIVENESS COMPARED WITH INFUSIONAL 5-FLUOROURACIL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75836-8&doi=10.1016/S1098-3015(10)75836-8
First page :
Section Title :
Open access? :
No
Section Order :
82